obesity drug news today glp-1 today Weight loss with medicines does not result in a disproportionate loss of muscle mass or function in obese mice and humans: Cell Reports Medicine GLP-1 weight loss drugs to

Food and Drug Administration on Monday approved the first-ever GLP-1 pill for obesity from Wegovy maker Novo Nordisk, a landmark decision that health experts say could open up treatment access to more patients

Preclinical studies have clearly demonstrated that GLP-1RAs effectively reduce hepatic macrophage infiltration and suppress expression of TNF- , IL-6, and other pro-inflammatory mediators in animal models of MASLD (21, 22)

The longer answer involves navigating scope of practice questions, state-by-state prescribing regulations, telehealth restrictions, and the evolving economics of weight management as a service line

The injection is given subcutaneously once a week